Quantum computing stock D-Wave Quantum (QBTS) has delivered a sharp rally over the past year, with its stock up 1,244% in the last 12 months and gaining over 90% so far in 2025. Its quantum annealing tech, built to solve complex problems like drug discovery, is delivering real-world results. In Q1 2025, revenue surged 509% year-over-year to a record $15 million, with momentum expected to stay strong.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Also, Wall Street remains upbeat on the stock. For example, Top-rated analyst Sujeeva De Silva of Roth MKM just raised his price target on QBTS to $18 from $12, keeping a Buy rating. He sees growing quantum computing demand from both commercial and AI sectors, with D-Wave well-positioned to benefit. Given these drivers, it’s a good time to see who owns shares of QBTS.
Now, according to TipRanks’ ownership page, public companies and individual investors hold the largest share of QBTS at 74.65%. They’re followed by insiders and ETFs, each owning 8.51%. Mutual funds and other institutional investors hold 4.38% and 3.95%, respectively.
Digging Deeper into QBTS’s Ownership Structure
Looking closely at top shareholders, Public Sector Pension Investment Board owns the highest stake in QBTS at 6.60%. Following that is Vanguard, who owns about 3.45% of the company.
Among the top ETF holders, the Vanguard Total Stock Market ETF (VTI) owns a 2% stake in D-Wave Quantum stock, followed by the Defiance Quantum ETF (QTUM), with a 1.85% stake.
Moving to mutual funds, Vanguard Index Funds holds about 3% of QBTS. Meanwhile, Fidelity Concord Street Trust owns 0.50% of the company.
Is D-Wave a Good Stock to Buy?
D-Wave is currently covered by six Wall Street analysts, all of whom hold a bullish outlook. The stock carries a Strong Buy consensus rating, with all six analysts assigning a Buy rating over the past three months. However, QBTS’s average price target of $14.20 suggests approximately 11.25% downside potential over the next twelve months.
